Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective,Randomized,Open Label,European Multicenter Study of the Efficacy of the Linezolid-rifampin Combination Versus Standard of Care in the Treatment of Gram-positive.

NCT01757236 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT01757236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01757236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective,Randomized,Open Label,European Multicenter Study of the Efficacy of the Linezolid-rifampin Combination Versus Standard of Care in the Treatment of Gram-positive.
Lead sponsor
University Hospital, Tours
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2012
Completion date
April 30, 2016
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hip prosthetic joint infection